Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06169813

E-cigarette Harm Reduction Among PLWHA in South Africa

Evaluating Smoking Cessation and Harm Reduction Approaches Among People Living With HIV/AIDS in South Africa

Status
Active Not Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
106 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this pilot randomized controlled trial study aims to address the unmet need for feasible and efficacious strategies for reducing combustible cigarette (CC) use among people living with HIV/AIDS (PLWHA) in South Africa, which has the potential to significantly improve the health and long-term survival of PLWHA CC smokers. Using the proposed intervention, based on the Information-Motivation-Behavioral Skills (IMB), and a simultaneous embedded mixed methods approach, the investigators will evaluate a telehealth program targeting CC harm reduction, comparing E-cigarettes (EC) to nicotine replacement therapy (NRT) that is enhanced by integrating ecological momentary intervention (EMI) texting. As such, this proposal will significantly build research capacity in South Africa to conduct telehealth tobacco treatment interventions using innovative EMI approaches enhancing participants' engagement, as well as state-of-the art evaluation approaches.

Conditions

Interventions

TypeNameDescription
OTHERNicotine Replacement Therapy (NRT)NRT (daily patches and lozenges). NRT strength will be according to the established dosing guidelines for tobacco treatment. NRT is the standard of care in tobacco treatment and helped reduce CPD in prior trials
OTHERE-Cigarette (EC)EC with single-use pods. Nicotine - 48 mg/ ml (4.8% nicotine) concentration.
BEHAVIORALCounselingEach participant will receive up to 5-motivational counseling sessions. The first session will also include orientation of EMA/EMI texting.

Timeline

Start date
2025-04-15
Primary completion
2025-10-24
Completion
2026-02-27
First posted
2023-12-14
Last updated
2025-11-03

Locations

1 site across 1 country: South Africa

Source: ClinicalTrials.gov record NCT06169813. Inclusion in this directory is not an endorsement.